Stan Wang, a physician-scientist, and two physicists, Nabiha Saklayen and Marinna Madrid, teamed up in 2017 to start Cellino.

Cellino’s purpose is to build a precision platform that personalizes human cells for all. Stem cell-derived regenerative medicines are poised to cure some of the toughest diseases within this decade, including Parkinson’s, diabetes, and heart disease. Patient-specific cells provide the safest, most effective cures for these indications. However, current autologous processes are not scalable due to extensive manual handling, high variability, and expensive facility overhead. Cellino’s vision is to enable healthier lives worldwide with personalized human cells.